Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

2.3%

3 terminated/withdrawn out of 132 trials

Success Rate

93.9%

+7.3% vs industry average

Late-Stage Pipeline

21%

28 trials in Phase 3/4

Results Transparency

3 of 46 completed trials have results

Key Signals

15 recruiting3 with results

Enrollment Performance

Analytics

N/A

48(51.1%)

Phase 4

20(21.3%)

Phase 2

14(14.9%)

Phase 3

8(8.5%)

Phase 1

4(4.3%)

94Total

N/A(48)

Phase 4(20)

Phase 2(14)

Phase 3(8)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (132)

Showing 20 of 132 trials

NCT07852637Phase 4Not Yet Recruiting

Edoxaban Versus Apixaban in Cancer-Associated Venous Thromboembolism

Role: collaborator

NCT07324720Not ApplicableRecruiting

Strategic Comparison Of Ischemia-based Versus Plaque Burden and vulnErability-based Revascularization in High-Risk Coronary Artery Disease Patients

Role: collaborator

NCT06257394Phase 2Recruiting

Treatment of Pediatric Very High-risk Acute Lymphoblastic Leukemia in Korea

Role: collaborator

NCT05827549Phase 2Recruiting

Evaluation of Treatment Efficacy According to Risk Group in Relapsed Childhood Acute Lymphoblastic Leukemia

Role: collaborator

NCT06099366Phase 2Recruiting

Treatment of Newly Diagnosed Standard Risk Acute Lymphoblastic Leukemia in Children

Role: collaborator

NCT06769087Not ApplicableEnrolling By Invitation

Comparing Immediate Removal and Postoperative 1 Day of Urinary Catheter After Colorectal Cancer Surgery

Role: lead

NCT07668739Phase 4Not Yet Recruiting

Efficacy of Verciguat in TR and RV Failure

Role: collaborator

NCT07240844Phase 4Recruiting

Enavogliflozin for the Management of Patients With Amyloid CardiomyopaThy

Role: lead

NCT07641582Not ApplicableRecruiting

Prediction of Atrial Fibrillation Using Polygenic Risk Score

Role: lead

NCT06388720Phase 2Recruiting

The Clinical Effectiveness and Safety of Intravesical Mitomycin-C and Gemcitabine Sequential Therapy

Role: collaborator

NCT07583134Phase 4Not Yet Recruiting

Impact of Propranolol Strategies on Myocardial Injury After Breast Cancer Surgery

Role: collaborator

NCT06330038Phase 4Recruiting

Anesthesia and Non-small Cell Lung Cancer Recurrence

Role: collaborator

NCT07505290Not ApplicableActive Not Recruiting

Efficacy of the Korean PEERS® for Preschoolers (PEERS®-PS-K) Social Skills Intervention: A Randomized Controlled Trial for Children With Autism Spectrum Disorder

Role: collaborator

NCT06967441Recruiting

Respiratory Virus Infections in Acute Heart Failure

Role: collaborator

NCT05369182Active Not Recruiting

Multicenter Registry of Coronary Flow-Derived Indexes for Coronary Microvascular Disease (Multicenter FLOW-CMD Registry)

Role: collaborator

NCT05221931Not ApplicableActive Not Recruiting

Drug-Coated Balloon in Patients With High Bleeding Risk

Role: collaborator

NCT04014803Phase 4Recruiting

Aspirin and a PoTent P2Y12 Inhibitor Versus Aspirin and Clopidogrel in Patients Undergoing PCI for Complex Lesion

Role: collaborator

NCT06086665Completed

The Real World Efficacy and Safety of Niraparib in Korean Women With Primary and Recurrent Epithelial Ovarian Cancer

Role: collaborator

NCT07380867Not ApplicableEnrolling By Invitation

Confirming the Accuracy of Endoscopic Marking Using a New Marker, a Novel Luminomarker, in Lesion Marking Before Colorectal Cancer Surgery.

Role: lead

NCT07345026Not ApplicableNot Yet Recruiting

Acellular Dermal Matrix(SureDerm BCS) in Breast-Conserving Surgery for Breast Cancer Patients

Role: lead